CCC
Chelsea Counsel Company Portfolio holdings
AUM
$202M
1-Year Return
15.79%
This Quarter Return
+7.39%
1 Year Return
+15.79%
3 Year Return
+54.61%
5 Year Return
+107.31%
10 Year Return
+257.05%
AUM
$512M
AUM Growth
+$19.9M
(+4%)
Cap. Flow
-$12.3M
Cap. Flow
% of AUM
-2.4%
Top 10 Holdings %
Top 10 Hldgs %
34.55%
Holding
137
New
12
Increased
33
Reduced
43
Closed
8
Top Buys
| 1 |
Plains All American Pipeline
PAA
|
+$1.74M |
| 2 |
ABB
ABB Ltd.
ABB
|
+$926K |
| 3 |
Qualcomm
QCOM
|
+$805K |
| 4 |
VRN
Veren
VRN
|
+$713K |
| 5 |
ETP
Energy Transfer Partners L.p.
ETP
|
+$677K |
Top Sells
| 1 |
UN
Unilever NV New York Registry Shares
UN
|
+$7.9M |
| 2 |
CBI
Chicago Bridge & Iron Nv
CBI
|
+$4.29M |
| 3 |
Duke Energy
DUK
|
+$2.5M |
| 4 |
APC
Anadarko Petroleum
APC
|
+$1.64M |
| 5 |
Apple
AAPL
|
+$1.15M |
Sector Composition
| 1 | Energy | 21.63% |
| 2 | Industrials | 20.16% |
| 3 | Healthcare | 10.09% |
| 4 | Communication Services | 9.51% |
| 5 | Consumer Staples | 9.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Biogen
BIIB
$20.9B
| $512K | 0.1% |
+1,623
| New | +$512K |
|
77
Ventas
VTR
$31.8B
| $497K | 0.1% |
6,792
| – | – |
|
78
NOV
NOV
$4.79B
| $481K | 0.09% |
5,835
-3,076
| -35% | -$254K |
|
79
Sempra
SRE
$55B
| $477K | 0.09% |
9,110
| – | – |
|
80
McKesson
MCK
$88.3B
| $466K | 0.09% |
2,500
+100
| +4% | +$18.6K |
|
81
PepsiCo
PEP
$194B
| $463K | 0.09% |
5,180
-2,000
| -28% | -$179K |
|
82
Bank of America
BAC
$377B
| $437K | 0.09% |
28,425
-4,600
| -14% | -$70.7K |
|
83
Visa
V
$660B
| $421K | 0.08% |
8,000
+4,000
| +100% | +$211K |
|
|
GTU
84
DELISTED
CENTRAL GOLD TR (CANADA)
GTU
| $418K | 0.08% |
8,810
-1,100
| -11% | -$52.2K |
|
85
Curtiss-Wright
CW
$19.7B
| $394K | 0.08% |
6,016
| – | – |
|
86
Goldman Sachs
GS
$238B
| $385K | 0.08% |
2,300
| – | – |
|
87
Essential Utilities
WTRG
$10.7B
| $376K | 0.07% |
14,338
| – | – |
|
88
Lockheed Martin
LMT
$111B
| $360K | 0.07% |
2,240
+500
| +29% | +$80.4K |
|
89
Wells Fargo
WFC
$261B
| $359K | 0.07% |
6,834
| – | – |
|
90
APA Corp
APA
$8.27B
| $352K | 0.07% |
3,500
-500
| -13% | -$50.3K |
|
91
AB InBev
BUD
$115B
| $345K | 0.07% |
+3,000
| New | +$345K |
|
92
Equity Residential
EQR
$25.1B
| $340K | 0.07% |
+5,400
| New | +$340K |
|
93
Gilead Sciences
GILD
$139B
| $339K | 0.07% |
4,094
-200
| -5% | -$16.6K |
|
94
Mercury Insurance
MCY
$4.4B
| $332K | 0.06% |
7,050
+300
| +4% | +$14.1K |
|
95
Occidental Petroleum
OXY
$44.8B
| $330K | 0.06% |
3,357
-313
| -9% | -$30.8K |
|
|
DHC
96
Diversified Healthcare Trust
DHC
$1.07B
| $304K | 0.06% |
12,613
-16,664
| -57% | -$402K |
|
97
BP
BP
$87.7B
| $293K | 0.06% |
6,785
| – | – |
|
98
Berkshire Hathaway Class B
BRK.B
$1.06T
| $285K | 0.06% |
2,249
| – | – |
|
99
Ecolab
ECL
$77.4B
| $278K | 0.05% |
2,500
| – | – |
|
100
Pfizer
PFE
$135B
| $264K | 0.05% |
9,382
-1,038
| -10% | -$29.2K |
|